Navigation Links
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/10/2010

LYNBROOK, N.Y., March 10 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2009.  

"2009 was a great year for XIAFLEX, highlighted by the recent FDA approval for the treatment of Dupuytren's contracture and its commercial availability on March 8th. We believe the drug has strong market potential as the first and only FDA-approved nonsurgical treatment for patients suffering from this debilitating condition of the hand," said Thomas Wegman, President of BioSpecifics. "We have spent many years dedicated to bringing this drug to the market, and we are very much looking forward to its commercial success now that it's available to patients. We also look forward to the further clinical development of XIAFLEX for Peyronie's disease and frozen shoulder as well as additional promising indications."

Financial Results

The Company reported a net loss of

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
3. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
4. BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytrens Contracture
5. BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
6. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
7. BioSpecifics Technologies Corp. to Present at Cowen and Company 30th Annual Health Care Conference
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on March 10, 2010
9. BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytrens Contracture
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... material development to shareholders, EPGL has opened negotiations ... exclusive Option to License their new ophthalmic technologies. ... Global Communications, Inc. have co-developed new contact lens ... filings.  It is estimated by some industry experts ...
(Date:3/30/2015)... WHITE PLAINS, N.Y. , March 30, 2015 /PRNewswire-USNewswire/ ... developing new treatments for patients with a rare and ... from a recent licensing agreement with a new biotechnology ... has been funding this work, led by Assistant Professor ... Tomasz Cierpicki , Ph.D., at the University of Michigan, ...
(Date:3/30/2015)... , March 30, 2015  Rigrodsky & Long, P.A.: ... Inc. (NASDAQ GM: ASPX )? , Did you ... , Do you think the proposed buyout price is ... rights? Rigrodsky & Long, P.A. ... board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" or the ...
Breaking Medicine Technology:CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 2CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 3Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
... Sept. 29, 2011 CVS/pharmacy,s ExtraCare Rewards ... 69 million active cardholders, today announced the continuation of ... fun and useful digital resources on CVS.com and the ... ExtraBucks® Rewards, just in time for the October 1 ...
... Reportlinker.com announces that a new market research ... Global Medical Specialty Bags Industry ... This report analyzes the worldwide markets ... by the following product segments - Bile ...
Cached Medicine Technology:CVS/pharmacy Continues Digital "MoneyTrashers" Campaign, Enlists Shoppers to Pledge to "Stop Money Trashing" 2CVS/pharmacy Continues Digital "MoneyTrashers" Campaign, Enlists Shoppers to Pledge to "Stop Money Trashing" 3Global Medical Specialty Bags Industry 2Global Medical Specialty Bags Industry 3Global Medical Specialty Bags Industry 4Global Medical Specialty Bags Industry 5Global Medical Specialty Bags Industry 6Global Medical Specialty Bags Industry 7Global Medical Specialty Bags Industry 8Global Medical Specialty Bags Industry 9Global Medical Specialty Bags Industry 10Global Medical Specialty Bags Industry 11Global Medical Specialty Bags Industry 12Global Medical Specialty Bags Industry 13Global Medical Specialty Bags Industry 14Global Medical Specialty Bags Industry 15Global Medical Specialty Bags Industry 16Global Medical Specialty Bags Industry 17Global Medical Specialty Bags Industry 18Global Medical Specialty Bags Industry 19Global Medical Specialty Bags Industry 20Global Medical Specialty Bags Industry 21Global Medical Specialty Bags Industry 22Global Medical Specialty Bags Industry 23
(Date:3/30/2015)... 30, 2015 In its 2015 survey ... Robins & Morton sixth among the top general contractors ... Morton has specialized in healthcare construction for more than ... & Morton ranked on the list with $657 million ... company built 2.6 million square feet with 82 percent ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Southern Med ... and defective medical devices, has filed a Mirena ... whose baby died following his premature birth in 2012. ... Circuit Court, alleges that the Mirena IUD failed to ... also made the device difficult to remove. The inability ...
(Date:3/30/2015)... 30, 2015 Textile Exchange, a global ... industry, today announced the latest version of its ... standard that can be applied to any waterfowl-based supply ... hatchling to end product. The goal of the RDS ... welfare and to enable traceability so that products can ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 “We are ... 2015 Endeavor Awards on May 30 in Los Angeles,” ... many amazing volunteers pilots nominated from a nationwide call ... Billings with Angel Flight Mid-Atlantic, Richard Durden with LightHawk ... organization represented by the award recipients will receive a ...
(Date:3/30/2015)... 2015 On March 11, 2015, Elle Magazine, ... Fat,” details six new treatment options for dealing with stubborn, ... is a topical product. The other three technologies use devices ... ) or freezing cold ( CoolSculpting ) to kill fat ... available to us to permanently remove unwanted fat," says Dr. ...
Breaking Medicine News(10 mins):Health News:Modern Healthcare Ranks Robins & Morton No. 6 Contractor 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:2015 Endeavor Awards Recipients Announced 2Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2
... of shut-eye a night at higher death risk, study suggests ... 7.5 hours of sleep a night may increase the risk ... say Japanese researchers. , They tracked the sleep of 1,255 ... about 50 months. During the follow-up, there were 99 cardiovascular ...
... Ignagni, President,and CEO of America,s Health Insurance Plans ... announced by CMS on agent and broker,compensation for ... taking this important step to provide guidelines,for agent ... receive the,information they need during open enrollment, that ...
... N.J., Nov. 10 Wyeth (NYSE: WYE ),announced ... Healthcare,Conference on Wednesday, November 12, 2008 at 11:30 a.m. ... Executive Vice,President, Technical Operations and Product Supply, Wyeth Pharmaceuticals., ... at, http://www.wyeth.com and available for replay following the ...
... Nov. 10 The United Spinal Association, (http://www.UnitedSpinal.org ) ... VetsFirst (http://www.VetsFirst.org ) an interactive gateway to,information on ... their,families., Paul Tobin, President of United Spinal Association ... it is only fitting,that as we honor the brave ...
... Nov. 10 According to the American,Diabetes Association ... the,United States who have diabetes and approximately one ... In 2007, 17.5 million diagnosed,diabetics in the U.S. ... In response to this growing epidemic, Health Management ...
... of members of Healthy York Network, re-opens in centrally located Family ... ... 10 Last month, the Healthy,Community Pharmacy celebrated its grand re-opening ... will improve access to,health care for thousands of local York residents ...
Cached Medicine News:Health News:Poor Sleep, Hypertension a Dangerous Combination 2Health News:United Spinal Association Launches VetsFirst.org Help Center: The Next Generation Veterans Service Organization 2Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 2Health News:Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife 3Health News:Capital BlueCross Sponsors Healthy Community Pharmacy's Move to New Community-Focused Location in York 2Health News:Capital BlueCross Sponsors Healthy Community Pharmacy's Move to New Community-Focused Location in York 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000) ...
Medicine Products: